PROTEOMICS · 2008 · 50 citations · 44 references
MedicineMolecular BiologyOncologyCarcinogenesisGene ExpressionMolecular OncologyHepatic PathophysiologyHepatocellular CarcinomaLiver CancerLiver DiseaseMyc Family OncogenesViral HepatitisHepatitis C InfectionHepatocellular Carcinoma PathogenesisLiver Disease-related Protein ChangesMaldi-tof Mass SpectrometryProfilingUpstream Binding FactorViral Hepatitis-associated CarcinogenesisWestern Blot Analysis
Hepatocellular carcinoma (HCC) is a major cause of cancer worldwide and is often characterized by aggressive tumour behaviour and poor prognosis. One of the major etiologies is hepatitis B or C virus (HBV or HCV) infections. In order to better comprehend the molecular mechanisms involved in HCC progression, we performed a systematic analysis on moderately and poorly differentiated human HCC tissues using 2-D DIGE coupled to MALDI-TOF/TOF MS. A total of 52 and 26 proteins were found to be dysregulated in moderately and poorly differentiated HCC tissues, respectively. For the first time, the over-expression of a novel protein family, far upstream binding proteins (FUBPs) was identified in both stages of HCC and confirmed by western blots. FUBPs are of particular interest due to their transcriptional activity on the oncogene, c-myc. It has generally been accepted that c-myc plays an important role in HCC progression but its exact activators remain poorly understood. Interestingly, we also observed elevated c-myc levels in the tissues used in this study by western blot analysis. We therefore propose that the FUBP family of proteins may be one of the possible upstream players that are involved in modulating the c-myc levels in HCC tumorigenesis.
44
Josep M. Llovet, Andrew K. Burroughs, Jordi Bruix · The Lancet · 2003 · 3.6K citations
The International Protein Index: An integrated database for proteomics experiments
Paul Kersey, Jorge Duarte, Allyson L. Williams et al. · PROTEOMICS · 2004 · 696 citations